NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...

Bright Minds Biosciences has developed a unique platform of highly selective serotonergic agonists exhibiting selectivity at ...

A new non-invasive treatment for depression, which has been shown to deliver remission for one third of its patients, is to ...

St John of God Hospital in Dublin has said it is the first hospital in Ireland to introduce a special treatment for patients ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.